Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
06/2010
06/24/2010US20100158950 Use of tetanus toxin to amplify inadequate voluntary muscle contraction or to improve muscle tone in an animal actively vaccinated against the toxin and a regimen for treatment
06/24/2010US20100158906 Use of recombinant monoclonal antibody with specific binding activity for cell surface phosphorylated glycoprotein in diagnosis and treatment of immune, cell proliferative and inflammatory disorders
06/24/2010US20100158888 Use of alkaline phosphatase to maintain healthy tissue mass in mammals
06/24/2010CA2747062A1 Myostatin binding proteins
06/24/2010CA2746764A1 New polymorphic form of 1- (4- { l- [ (e) -4-cyclohexyl--3-trifluoromethyl-benzyloxyimino] -ethyl) -2-ethyl-benzy l) -azetidine-3-carboxylic
06/24/2010CA2743397A1 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
06/23/2010EP2197890A1 Mitochondrial compositions and uses thereof
06/23/2010EP2197848A1 Novel r,r'-atracurium salts
06/23/2010CN101748120A Interference RNA interfering muscle specific E3 ubiquitin protein ligase gene, carrier containing same and application thereof
06/23/2010CN101745088A Damp pain-relieving rubber paste and making method thereof
06/23/2010CN101744929A Applications of Chinese medicinal composition to preparation of medicament for treating facial paralysis
06/23/2010CN101020659B 9-aminoalkylamido-1-azabenznthrone derivative and its synthesis and application
06/22/2010US7741349 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitors for seine/threonine kinases, phosphatases; Alzheimer'
06/22/2010US7741343 6H-oxazolo[4,5 e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
06/22/2010US7741312 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries
06/22/2010US7741047 Using histone binding protein (RBAp48) as evaluative tool in identifying modulators for treatment of sjogren's syndrome
06/22/2010CA2444489C Benzimidazolone compounds
06/22/2010CA2444198C Nociceptin analogs
06/22/2010CA2443938C Spiroindene and spiroindane compounds as opioid ligands useful for treating pain
06/22/2010CA2410408C 2-aminoalkylthieno[2,3-d]pyrimidines
06/22/2010CA2389553C Heteroaryl-diazabicycloalkanes
06/22/2010CA2382355C Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent
06/17/2010WO2010068264A2 Novel formulations to inhibit cyclooxygenase and pro-inflammatory cytokine mediated diseases
06/17/2010US20100152186 Triazolyl pyridyl benzenesulfonamides
06/17/2010US20100152116 Treatment of amyotrophic lateral sclerosis
06/17/2010US20100151041 Hypersaturated gas in liquid
06/17/2010US20100150995 Process for the production of high-purity 2,4'-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions that contain the latter, as well as active ingredient formulations that contain tolperisone
06/17/2010US20100150909 PTHrP-DERIVED MODULATORS OF SMOOTH MUSCLE PROLIFERATION
06/17/2010US20100150893 Methods of organ regeneration
06/16/2010EP2196203A2 Use of amino-acid based compositions for the treatment of sarcopenia
06/16/2010EP2194782A1 Methods for promoting wound healing and muscle regeneration with the cell signaling protein nell 1
06/16/2010EP1364010B1 Immunomodulatory polynucleotides and methods of using the same
06/16/2010CN1500095B Polymer conjugates of neublastin and methods of using ssame
06/16/2010CN101735230A Bisbenzylisoquinoline derivative and preparation and application thereof
06/16/2010CN101732312A Huperzine A oral formulation and a preparation method thereof
06/15/2010US7737116 Modified and stabilized GDF propeptides and uses thereof
06/15/2010US7736622 Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
06/15/2010CA2393650C Novel 1,8-naphthyridin-2(1h)-one derivatives
06/15/2010CA2341700C Compositions and methods for treatment of mitochondrial diseases
06/15/2010CA2335505C Novel triterpenoids and their use for the treatment and prevention of cancer, inflammatory disorders, and neurodegenerative disease
06/10/2010WO2010064707A1 2h-chromene compound and derivative thereof
06/10/2010WO2010064597A1 Piperidine derivative
06/10/2010WO2010064248A2 Methods of diagnosing and treating motor neuron diseases
06/10/2010US20100145071 Small molecule inhibitors of rotamase enzyme activity
06/10/2010US20100144876 Modulator
06/10/2010US20100144871 Treating muscle wasting with selective androgen receptor modulators
06/10/2010US20100144799 Optical enantiomers of phenyramidol and process for chiral synthesis
06/10/2010US20100144766 Composition and method for treating or preventing skeletal muscle fibrosis
06/10/2010US20100144665 Treatment of statin side effects
06/10/2010US20100143452 Polyphenol containing compositions
06/10/2010US20100143420 Multi-phasic pharmaceutical formulations of poorly water-soluble drugs for reduced fed/fasted variability and improved oral bioavailability
06/10/2010US20100143413 Apparatus and method for treating a neuromuscular defect
06/10/2010US20100143382 Modulation of rhamm (cd168) for selective adipose tissue development
06/10/2010CA2745356A1 2h-chromene compound and derivative thereof
06/09/2010EP2193788A1 Pharmaceutical compositions comprising colloidal silicon dioxide
06/09/2010EP2193200A1 Nucleic acid codifying for a utrophin transcription specific regulating protein, protein codified thereby and uses thereof
06/09/2010EP2192898A1 Composition and method for increasing the anabolic state of muscle cells
06/09/2010EP1497273B1 Hydroxamic acid derivatives
06/09/2010CN1871000B Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pain
06/09/2010CN1662511B Pharmaceutical salts of reboxetine
06/09/2010CN101730539A Fibrin gel for controlled release of tgf-beta and uses thereof
06/09/2010CN101723939A Isopentenyl-oxyl substituted dehydrogenized silybin ether and preparation method and application thereof
06/09/2010CN101721706A Medicine composition containing matrine class alkaloid, preparation method and pharmaceutical application
06/08/2010US7732622 Naphthalene derivatives
06/08/2010US7732480 Bicyclic compounds as modulators of androgen receptor function and method
06/08/2010US7731961 Methods of increasing muscle mass or muscle strength using antibody inhibitors of GDF-8
06/08/2010CA2440553C 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
06/08/2010CA2439241C Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
06/08/2010CA2369300C Water-soluble compositions of bioactive lipophilic compounds
06/03/2010US20100137352 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
06/03/2010US20100136623 Mutations in ion channels
06/03/2010US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation
06/02/2010EP2191832A1 Quinazoline derivatives which promote the release of parathyroid hormone
06/02/2010EP2190810A1 Compounds isolated from antrodia cinnamomea and use thereof
06/02/2010CN1938042B Use of aromatic cation peptide in preparing medicine for relieving oxidative damage
06/02/2010CN101717410A Phosphorus-containing compounds & uses thereof
06/02/2010CN101716320A Externally applied medical composition for treating orthopedic diseases and preparation method thereof
06/02/2010CN101716152A Flunarizine hydrochloride pills and preparation method thereof
06/01/2010US7727952 Methods for treating spinal and bulbar muscular atrophy using LHRH analogs
06/01/2010CA2490120C Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
06/01/2010CA2443456C Novel atisane compounds and use thereof
05/2010
05/27/2010WO2010058846A1 4,6-diaminonicotinamide compound
05/27/2010WO2010057833A1 Compounds for treatment of duchenne muscular dystrophy
05/27/2010WO2010019911A3 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions
05/27/2010US20100130591 Multiple exon skipping compositions for dmd
05/27/2010US20100130483 Novel diazabicyclic aryl derivatives
05/27/2010US20100130480 Benzoquinoline inhibitors of vesicular monoamine transporter 2
05/27/2010US20100130456 Drug Combination and Its Use in the Treatment of Muscle Loss
05/27/2010US20100130405 Biglycan and related therapeutics and methods of use
05/27/2010US20100129353 Combination and treatment for multiple sclerosis
05/26/2010EP2189526A1 Antibody binding specifically to tdp-43 aggregate
05/26/2010EP2189475A2 Fibroblast growth factor-like polypeptides
05/26/2010CN1681811B Azolidinone-vinyl fused-benzene derivatives
05/26/2010CN101712649A Lotus leaf extract, monomer component and application thereof
05/26/2010CN101711857A Film coating agent for treating whitevein and preparation method thereof
05/26/2010CN101711758A Application of apigenin in preparing medicament for preventing and treating diseases caused by ischemic injuries of humans
05/26/2010CN101019814B Application of non-depolarizing muscular relaxant in preventing and eliminating facial wrinkles
05/25/2010US7723505 EAAT2 promoter and uses thereof
05/25/2010US7723480 Leucine-based motif and clostridial neurotoxins
05/25/2010US7723479 BSL3 polypeptides
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 233